Filter posts

BIO Coalition Submits Patent Reform Letter to Congress

BIO, alongside a coalition of patent holders and inventors, submitted a letter to the chairmen …

Patent Cases Down by 40% in 2014

The number of new patent cases filed in federal court has dropped by an astonishing …

Should the USPTO Allow the Patenting of Living Organisms?

Last year, a question was submitted to the GMO advocacy website GMOAnswers about whether or …

Patent Parameters

Supreme Court Finds Naturally Occurring DNA to Be Patent Ineligible Last summer, the Supreme Court …

Supreme Court Decision on Web Content Delivery to Impact Biotech Patents

Earlier this month, in Limelight Networks, Inc. v. Akamai Technologies, Inc., the Supreme Court issued …

Nautilus v. Biosig, Baxter v. Fresenius and Limelight v. Akamai

BIO weighed in on three Supreme Court cases in the last few months whose outcome …

Patently Biotech’s Top Articles of 2013

Intellectual property featured prominently in 2013’s public discourse. Gene patents, patent trolls, India’s anti-patent actions, …

Myriad Supreme Court Decision: BIO’s Statement

Statement On U.S. Supreme Court Review Of Isolated DNA Patents Washington, D.C. (June 13, 2013) …

The Justness of Gene Patents

Most of the biotechnology world awaits the U.S. Supreme Court’s answer to the Question Presented, …

Whole Genome Sequencing and Myriad Supreme Court Case: Nothing to See Here

Bio IT World just published an article stating that the Myriad Supreme Court case will …